Treatments for Hypertension in Type 2 Diabetes-Non-pharmacological and Pharmacological Measurements#

Author(s): Kazuko Masuo

Journal Name: Current Hypertension Reviews

Volume 11 , Issue 1 , 2015

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Obesity, hypertension, obesity-related hypertension such as hypertension with diabetes are growing health problems. Obesity, hypertension and diabetes are important, independent risk factors for the onset and development of cardiovascular diseases. Hypertension in obesity is characterized by stimulation of the renin-angiotensin-aldosterone system (RAAS), elevated sympathetic activity, insulin resistance and selective leptin resistance. It is known that these characteristics, even in isolation, constitute risk factors for cardiovascular disease onset and progression. Therefore, pharmacological treatments should be selected based on favourable effects on insulin resistance, stimulated RAAS and sympathetic nervous systems.

Keywords: Hypertension, insulin resistance, lifestyle modification, obesity, pharmacological treatments.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [61 - 77]
Pages: 17
DOI: 10.2174/1573402111666150416124617

Article Metrics

PDF: 75